COPENHAGEN, October 30 /PRNewswire/ -- Saxo Bank, the online trading and investment specialist, today launched SaxoMobileTrader for iPhone(TM). Offered to clients and partners the platform allows a user, with either an iPhone(TM) or an iPod Touch(TM), to stay updated with the markets, view their account status, and fully manage their positions and orders across multiple asset classes.

SaxoMobileTrader for iPhone(TM) enables clients to trade wherever they are, using the familiar and easy to navigate interface, allowing for convenient access to their portfolios.

LONDON, October 30 /PRNewswire/ -- SentryBay, a leader in real-time internet data security software, and ProjectFusion, a provider of secure internet-based datarooms, are collaborating to strengthen the access security of ProjectFusion's solutions, particularly from key logging spyware.

The companies have signed a Memorandum of Understanding which will see SentryBay's EntryProtect(TM) embedded within ProjectFusion's dataroom software applications making them 'key logger-proof'. This will further reduce customers' risk of corporate espionage, while protecting brand and corporate reputations.

PARIS, October 30 /PRNewswire/ --

Key Highlights for the Quarter - Revenues of Euro 4.065 Billion, Down 0.9% Sequentially - Adjusted(2) Gross Profit of Euro 1.320 Billion or 32.5% of Revenues (33.0% excl. one time item) - Adjusted(2) Operating Income(1) of Euro 40 Million or 1.0% of Revenues - Adjusted(2) Net Income (Group Share) of Euro 41 Million or Euro 0.02 per Diluted Share - Reported Net Loss (Group Share) of Euro (40) Million or Euro (0.02) per Diluted Share - Net Debt of Euro 600 Million at September 30, 2008 - Funded Status of Pensions and OPEB Shows Surplus of Euro 2.997 Billion at September 30, 2008

TORONTO, October 30 /PRNewswire/ --

- US Operators Can Now Utilize Rural Broadband Funding to Deploy Redline's RedMAX(TM) and RedCONNEX(TM) Products

Redline Communications Group Inc. (Redline) (TSX and AIM: RDL), a leading provider of WiMAX and broadband wireless infrastructure products, today announced that it has received USDA acceptance and Buy American status from the U.S. Department of Agriculture Rural Utility Services (RUS) for its RedMAX and RedCONNEX products. The acceptance will enable network operators in the United States to take advantage of a federal rural broadband funding program when deploying Redline's broadband wireless products in support of rural residential, business and community wireless services.

Last year, the New York Times reported that UPS managed to save 3 million gallons of gas in 2006 by altering the routes of delivery trucks to avoid left turns. According to the article, the company uses software called “package flow” to map out daily routes for drivers. Clearly, the method or “algorithm” this software employs to design efficient routes has sizeable economic (and greenhouse gas) consequences. And, not only is it far from perfect, but the general routing problem is so difficult that, well, if in the course of reading this article you happen upon an efficient solution, you will become immediately famous, at least among computer scientists.

Normal-weight women who carry out lots of vigorous exercise are approximately 30% less likely to develop breast cancer than those who don't exercise vigorously, according to a study of more than thirty thousand postmenopausal American women reported in Breast Cancer Research.  So a sedentary lifestyle can be a risk factor for the disease – even in women who are not overweight.

A "living fossil" tree species is helping a University of Michigan researcher understand how tropical forests responded to past climate change and how they may react to global warming in the future, according to research in the November issue of  Evolution.

Symphonia globulifera is a widespread tropical tree with a history that goes back some 45 million years in Africa, said Christopher Dick, an assistant professor of ecology and evolutionary biology who is lead author on the paper. It is unusual among tropical trees in having a well-studied fossil record, partly because the oil industry uses its distinctive pollen fossils as a stratigraphic tool. 

PARIS, October 30 /PRNewswire/ --

Key Highlights for the Quarter - Revenues of Euro 4.065 Billion, Down 0.9% Sequentially - Adjusted(2) Gross Profit of Euro 1.320 Billion or 32.5% of Revenues (33.0% excl. one time item) - Adjusted(2) Operating Income(1) of Euro 40 Million or 1.0% of Revenues - Adjusted(2) Net Income (Group Share) of Euro 41 Million or Euro 0.02 per Diluted Share - Reported Net Loss (Group Share) of Euro (40) Million or Euro (0.02) per Diluted Share - Net Debt of Euro 600 Million at September 30, 2008 - Funded Status of Pensions and OPEB Shows Surplus of Euro 2.997 Billion at September 30, 2008

Scientists have long been on the hunt for evidence of antimatter, matter's arch nemesis and a staple of science fiction in the last century, that might be left over from the very early Universe.  But the latest  results using data from NASA's Chandra X-ray Observatory and Compton Gamma Ray Observatory suggest the search is not going to get any easier.

Antimatter would be made up of elementary particles, each of which has the same mass as their corresponding matter counterparts --protons, neutrons and electrons -- but the opposite charges and magnetic properties. When matter and antimatter particles collide, theory says they annihilate each other and produce energy according to Einstein's famous equation, E=mc2.

New research from the University of Bristol brings stem cell therapies for heart disease one step closer. The findings reveal that our bodies' ability to respond to an internal 'mayday' signal may hold the key to success for long-awaited regenerative medicine.   Dr Nicolle Kränkel and colleagues at the Bristol Heart Institute have discovered how our bodies initiate DIY rescue and repair mechanisms when blood supply is inadequate, for example in diabetic limbs or in the heart muscle during heart attack. Their findings also provide a practical step to advance progress in stem cell therapies.